What is Pulmicort Medication (Budesonide)? - Know more about it!

by Thomas G. Pharmacist in the USA

Alternate Brand Name(s) : Entocort EC, Uceris, Pulmicort, Pulmicort Rotacap, Pulmicort Flexhaler, Pulmicort Nebuamp, Pulmicort Respules, Pulmicort Turbuhaler, Uceris,, Budecort

Active Ingredient: Budesonide

Budesonide may be a steroid that reduces inflammation within the body.

Budesonide is employed to treat mild to moderate regional enteritis .

Recommendation:

The recommended dose 9 mg orally once daily within the morning for up to eight weeks. Treatment are often tapered to six mg daily for two weeks before complete cessation.

Previously treated with bronchodilators alone:

I to 2 inhalations (200 mcg to 400 mcg) twice daily. Maximum dose: 2 inhalations (400 mcg) twice daily.

Previously treated with oral corticosteroids:

I to 4 inhalations (400 mcg to 800 mcg) twice daily. Maximum dose: 4 inhalations (800 mcg) twice daily.

Pulmicort Flexhaler (90 and 180 mcg/inh):

2 inhalations (360 mcg) twice daily. In some patients, a starting dose of 180 mcg twice daily could also be appropriate. the utmost dosage shouldn't exceed 360 mcg twice daily.

Treating mild to moderate colitis . it's going to even be used for other conditions as determined by your doctor.

Budesonide extended-release tablets may be a corticosteroid. It works by decreasing inflammation.

If you want to buy Pulmicort Medication at affordable prices so you Buy Pulmicort Medication and prescription drugs safely from Online Pharmacy USA.

Precautions:

Grapefruit and fruit juice may interact with budesonide and cause potentially dangerous effects. Avoid the utilization of grapefruit products while taking budesonide.

Avoid being near people that are sick or have infections. Call your doctor for preventive treatment if you're exposed to chicken pox or measles. These conditions are often serious or maybe fatal in people that are using budesonide.

Breastfeeding:

Budesonide, like other corticosteroids, is secreted in human milk. Data with budesonide delivered via dry powder inhaler indicates that the entire daily oral dose of budesonide in breast milk to the infant is approximately 0.3% to a quarter of the dose inhaled by the mother. The manufacturer recommends that caution be used when administering budesonide inhalation to nursing women. The manufacturer of oral budesonide recommends that thanks to the potential for serious adverse reactions in nursing infants, a choice should be made to discontinue nursing or to discontinue the drug, taking under consideration the clinical importance of the drug to the mother.